This compound is primarily used in the development of antiretroviral therapies targeting HIV-1. It functions by inhibiting the integrase enzyme, which is crucial for the viral replication process. By blocking this enzyme, the compound prevents the integration of viral DNA into the host genome, effectively halting the progression of the infection. Its application is significant in the treatment of HIV/AIDS, particularly in combination with other antiretroviral drugs to enhance efficacy and reduce the risk of drug resistance. Research is ongoing to optimize its pharmacological properties and improve patient outcomes.